DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Abnormal dendritic cell-poiesis in patients with lower-risk myelodysplastic syndromes
© 2020 the Author(s)., Myelodysplastic syndromes (MDS) are clonal hematopoietic stem/progenitor cell disorders associated with ineffective hematopoiesis and peripheral blood cytopenia(s). Mounting evidence suggests that immune system regulation plays an important role in MDS pathogenesis and progression.1 The Revised International Prognostic Scoring System (IPSS-R) divided MDS patients in four risk groups,2 in which, for simplicity's sake, very low, low, and intermediate risk groups can be united into one lower-risk MDS group, as higher-risk MDSs are closer to acute myeloid leukemia., This work was supported by SAF2014-52009-R (SA) and SAF2017-83289-R (SA) from the Spanish Ministry of Economy and Competitiveness and by the European Regional Development Funds (FEDER), B2017/BMD-3724 (SA) from the Comunidad de Madrid and Hay Esperanza Foundation (EA).